Brano Djenic, MD
Colon & Rectal Surgery · San Antonio, TXNPI 1649537556
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 81.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $4,840 and has fallen 92.8% since, to $350 in 2025.
Across 63 payments — averaging $89.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Johnson & Johnson$189
- Dilon Technologies, Inc.$145
- TELA Bio, Inc.$138
- Takeda Pharmaceuticals U.S.A., Inc.$116
- Medical Device Business Services, Inc.$112
- plus $329 from 12 others
What the payments were for
- Travel & lodging$1,41925%
- Food & beverage$2,24140%
- Education$2,00035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 42 | $4,631 |
| Johnson & Johnson(2 entities) | 3 | $189 |
| Dilon Technologies, Inc. | 1 | $145 |
| TELA Bio, Inc. | 2 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $116 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Trevena, Inc. | 1 | $100 |
| Amgen | 2 | $34 |
| Medtronic | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Mimedx Group, Inc. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Cook Biotech Incorporated | 1 | $19 |
| Kerecis Limited | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Biocompatibles, Inc. | 1 | $15 |
| Exelixis Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,818
- HemoBlast Bellows$145
- DARZALEX$125
- Ovitex$121
- EXKIVITY$116
- ENSEAL Product Family$112
- Echelon Powered Circular$112
How this compares
$5,660 in reported general payments places this provider in the 55th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 22 | $11,726 |
| Omeprazole | 127 | $1,755 |
| Sucralfate | 13 | $578 |
| Dicyclomine Hcl | 20 | $276 |
| Oxycodone Hcl | 37 | $246 |
| Hydrocortisone | 11 | $162 |
| Gabapentin | 24 | $141 |
| Neomycin Sulfate | 13 | $57 |
| Metronidazole | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in San Antonio
- Christopher de JesusSan Antonio$201K
- William LewisSan Antonio$85K
- Jaime MayoralSan Antonio$84K
- Michael KellerSan Antonio$50K
- Maria Martinez UgarteSan Antonio$47K
- James PrietoSan Antonio$16K
- Rolando SaenzSan Antonio$15K
- Mario AlcantaraSan Antonio$14K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.